Lucía Figueroa-Protti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lucía Figueroa-Protti has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Javier Mora
Centro de Investigación en Cirugía y Cáncer, Universidad de Costa Rica , San José
4 shared publications Clas Une
Institute of Health Research (INISA), University of Costa Rica, San José, Costa Rica
2 shared publicationsWarner Alpízar-Alpízar
Center for Research On Microscopic Structures (CIEMic), University of Costa Rica, San José, Costa Rica
2 shared publications- Warner Alpízar-Alpízar
Centro de Investigación en Estructuras Microscópicas, Universidad de Costa Rica , San José
2 shared publications - Wendy Malespín-Bendaña
Institute of Health Research (INISA), University of Costa Rica, San José, Costa Rica
2 shared publications - Adolfo Borges
Laboratorio de Biología Molecular de Toxinas y Receptores, Instituto de Medicina Experimental, Facultad de Medicina, Universidad Central de Venezuela, Caracas 50587, Venezuela
1 shared publication
Latest Publications
- Open Access
- 22 September 2026
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 10 (9)
Beyond PD-L1/PD-1: expression of PVR/TIGIT and TNFRSF14/BTLA axes in response to Helicobacter pylori and in gastric cancer lesions
Gastric cancer (GC) has a high mortality rate worldwide, mainly due to late detection and lack of effective treatments. Immune checkpoint (ICs) inhibitors have revolutionized cancer treatment; however, a substantial percentage of patients with GC do not respond to this treatment, which may be related to aspects underlying the conformation of the immune microenvironment during tumor development and progression. In this study, we assessed the role of Helicobacter pylori, the most recognized GC risk factor, in the concomitant induction of PD-L1, B7-H3, PVR, TNFRSF14, Gal-3, and Gal-9 in vitro. We also analyzed the expression of selected IC ligand-receptor axes in human GC lesions. The mRNA relative expression of PD-L1, PVR, and TNFRSF14 was significantly upregulated in human cell lines challenged with the bacterium. This was CagPAI dependent and further enhanced by PBMCs. In GC lesions, mRNA levels in the PVR/TIGIT and TNFRSF14/BTLA axes were higher than in the PD-L1/PD-1 axis. When the protein levels of these ICs axes were determined by flow cytometry on the different cell subpopulations of the tumor microenvironment, Tregs emerged as the lymphoid subpopulation contributing the most to the expression of PD-1, TIGIT, and BTLA receptors; their ligands were mainly expressed by GC cells. Our results suggest that, in addition to the PD-L1/PD-1 axis, PVR/TIGIT and TNFRSF14/BTLA axes may play a role in establishing an immunosuppressive microenvironment during GC development and progression. This study also highlights the potential relevance of Tregs as active players in shaping and maintaining an immunosuppressive milieu in GC lesions, in part through expression of ICs.
- 22 September 2026
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 10 (9)
Open AccessBeyond PD-L1/PD-1: expression of PVR/TIGIT and TNFRSF14/BTLA axes in response to Helicobacter pylori and in gastric cancer lesions
Gastric cancer (GC) has a high mortality rate worldwide, mainly due to late detection and lack of effective treatments. Immune checkpoint (ICs) inhibitors have revolutionized cancer treatment; however, a substantial percentage of patients with GC do not respond to this treatment, which may be related to aspects underlying the conformation of the immune microenvironment during tumor development and progression. In this study, we assessed the role of Helicobacter pylori, the most recognized GC risk factor, in the concomitant induction of PD-L1, B7-H3, PVR, TNFRSF14, Gal-3, and Gal-9 in vitro. We also analyzed the expression of selected IC ligand-receptor axes in human GC lesions. The mRNA relative expression of PD-L1, PVR, and TNFRSF14 was significantly upregulated in human cell lines challenged with the bacterium. This was CagPAI dependent and further enhanced by PBMCs. In GC lesions, mRNA levels in the PVR/TIGIT and TNFRSF14/BTLA axes were higher than in the PD-L1/PD-1 axis. When the protein levels of these ICs axes were determined by flow cytometry on the different cell subpopulations of the tumor microenvironment, Tregs emerged as the lymphoid subpopulation contributing the most to the expression of PD-1, TIGIT, and BTLA receptors; their ligands were mainly expressed by GC cells. Our results suggest that, in addition to the PD-L1/PD-1 axis, PVR/TIGIT and TNFRSF14/BTLA axes may play a role in establishing an immunosuppressive microenvironment during GC development and progression. This study also highlights the potential relevance of Tregs as active players in shaping and maintaining an immunosuppressive milieu in GC lesions, in part through expression of ICs.
- 1 January 2026
- Published by Colegio de Microbiólogos y Químicos Clínicos de Costa Rica in Revista del colegio de microbiólogos y químicos clínicos de Costa Rica
Investigaciones en Costa Rica sobre la respuesta inmune innata en el envenenamiento ofídico
Los envenenamientos por mordedura de serpiente son un problema de salud pública importante en países tropicales como Costa Rica. El veneno de serpientes de la familia Viperidae, particularmente de Bothrops asper, conocida como "terciopelo", provoca un daño local severo caracterizado por hemorragia, edema y mionecrosis, así como una regeneración tisular deficiente. Esta patología involucra una compleja interacción entre las toxinas del veneno, los mediadores inflamatorios y las células inmunológicas. En esta revisión se resumen las investigaciones que ha realizado el Instituto Clodomiro Picado en colaboración con otros grupos sobre la dinámica de los componentes de la inmunidad innata en el tejido muscular envenenado, con énfasis en la cinética de liberación de mediadores inflamatorios y la caracterización del infiltrado inflamatorio.
- 1 January 2026
- Published by Colegio de Microbiólogos y Químicos Clínicos de Costa Rica in Revista del colegio de microbiólogos y químicos clínicos de Costa Rica
Investigaciones en Costa Rica sobre la respuesta inmune innata en el envenenamiento ofídico
Los envenenamientos por mordedura de serpiente son un problema de salud pública importante en países tropicales como Costa Rica. El veneno de serpientes de la familia Viperidae, particularmente de Bothrops asper, conocida como "terciopelo", provoca un daño local severo caracterizado por hemorragia, edema y mionecrosis, así como una regeneración tisular deficiente. Esta patología involucra una compleja interacción entre las toxinas del veneno, los mediadores inflamatorios y las células inmunológicas. En esta revisión se resumen las investigaciones que ha realizado el Instituto Clodomiro Picado en colaboración con otros grupos sobre la dinámica de los componentes de la inmunidad innata en el tejido muscular envenenado, con énfasis en la cinética de liberación de mediadores inflamatorios y la caracterización del infiltrado inflamatorio.
- 6 March 2023
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 54 (2) , 791-801
Helicobacter pylori infection induces abnormal expression of pro-angiogenic gene ANGPT2 and miR-203a in AGS gastric cell line
Helicobacter pylori colonizes the stomach and induces an inflammatory response that can develop into gastric pathologies including cancer. The infection can alter the gastric vasculature by the deregulation of angiogenic factors and microRNAs. In this study, we investigate the expression level of pro-angiogenic genes (ANGPT2, ANGPT1, receptor TEK), and microRNAs (miR-135a, miR-200a, miR-203a) predicted to regulate those genes, using H. pylori co-cultures with gastric cancer cell lines. In vitro infections of different gastric cancer cell lines with H. pylori strains were performed, and the expression of ANGPT1, ANGPT2, and TEK genes, and miR-135a, miR-200a, and miR-203a, was quantified after 24 h of infection (h.p.i.). We performed a time course experiment of H. pylori 26695 infections in AGS cells at 6 different time points (3, 6, 12, 28, 24, and 36 h.p.i.). The angiogenic response induced by supernatants of non-infected and infected cells at 24 h.p.i. was evaluated in vivo, using the chicken chorioallantoic membrane (CAM) assay. In response to infection, ANGPT2 mRNA was upregulated at 24 h.p.i, and miR-203a was downregulated in AGS cells co-cultured with different H. pylori strains. The time course of H. pylori 26695 infection in AGS cells showed a gradual decrease of miR-203a expression concomitant with an increase of ANGPT2 mRNA and protein expression. Expression of ANGPT1 and TEK mRNA or protein could not be detected in any of the infected or non-infected cells. CAM assays showed that the supernatants of AGS-infected cells with 26695 strain induced a significantly higher angiogenic and inflammatory response. Our results suggest that H. pylori could contribute to the process of carcinogenesis by downregulating miR-203a, which further promotes angiogenesis in gastric mucosa by increasing ANGPT2 expression. Further investigation is needed to elucidate the underlying molecular mechanisms.
- 6 March 2023
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 54 (2) , 791-801
Helicobacter pylori infection induces abnormal expression of pro-angiogenic gene ANGPT2 and miR-203a in AGS gastric cell line
Helicobacter pylori colonizes the stomach and induces an inflammatory response that can develop into gastric pathologies including cancer. The infection can alter the gastric vasculature by the deregulation of angiogenic factors and microRNAs. In this study, we investigate the expression level of pro-angiogenic genes (ANGPT2, ANGPT1, receptor TEK), and microRNAs (miR-135a, miR-200a, miR-203a) predicted to regulate those genes, using H. pylori co-cultures with gastric cancer cell lines. In vitro infections of different gastric cancer cell lines with H. pylori strains were performed, and the expression of ANGPT1, ANGPT2, and TEK genes, and miR-135a, miR-200a, and miR-203a, was quantified after 24 h of infection (h.p.i.). We performed a time course experiment of H. pylori 26695 infections in AGS cells at 6 different time points (3, 6, 12, 28, 24, and 36 h.p.i.). The angiogenic response induced by supernatants of non-infected and infected cells at 24 h.p.i. was evaluated in vivo, using the chicken chorioallantoic membrane (CAM) assay. In response to infection, ANGPT2 mRNA was upregulated at 24 h.p.i, and miR-203a was downregulated in AGS cells co-cultured with different H. pylori strains. The time course of H. pylori 26695 infection in AGS cells showed a gradual decrease of miR-203a expression concomitant with an increase of ANGPT2 mRNA and protein expression. Expression of ANGPT1 and TEK mRNA or protein could not be detected in any of the infected or non-infected cells. CAM assays showed that the supernatants of AGS-infected cells with 26695 strain induced a significantly higher angiogenic and inflammatory response. Our results suggest that H. pylori could contribute to the process of carcinogenesis by downregulating miR-203a, which further promotes angiogenesis in gastric mucosa by increasing ANGPT2 expression. Further investigation is needed to elucidate the underlying molecular mechanisms.
- Open Access
- 15 February 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1072802
Helicobacter pylori infection induces gastric precancerous lesions and persistent expression of Angpt2, Vegf-A and Tnf-A in a mouse model
Introduction: Helicobacter pylori colonizes the gastric mucosa and induces chronic inflammation. Methods: Using a mouse model of H. pylori-induced gastritis, we evaluated the mRNA and protein expression levels of proinflammatory and proangiogenic factors, as well as the histopathological changes in gastric mucosa in response to infection. Five- to six-week-old female C57BL/6N mice were challenged with H. pylori SS1 strain. Animals were euthanized after 5-, 10-, 20-, 30-, 40- and 50-weeks post infection. mRNA and protein expression of Angpt1, Angpt2, VegfA, Tnf-α, bacterial colonization, inflammatory response and gastric lesions were evaluated. Results: A robust bacterial colonization was observed in 30 to 50 weeks-infected mice, which was accompanied by immune cell infiltration in the gastric mucosa. Compared to non-infected animals, H. pylori-colonized animals showed an upregulation in the expression of Tnf-A, Angpt2 and VegfA at the mRNA and protein levels. In contrast, Angpt1 mRNA and protein expression was downregulated in H. pylori-colonized mice. Conclusion: Our data show that H. pylori infection induces the expression of Angpt2, Tnf-A and Vegf-A in murine gastric epithelium. This may contribute to the pathogenesis of H. pylori-associated gastritis, however the significance of this should be further addressed.
- 15 February 2023
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 13, 1072802
Open AccessHelicobacter pylori infection induces gastric precancerous lesions and persistent expression of Angpt2, Vegf-A and Tnf-A in a mouse model
Introduction: Helicobacter pylori colonizes the gastric mucosa and induces chronic inflammation. Methods: Using a mouse model of H. pylori-induced gastritis, we evaluated the mRNA and protein expression levels of proinflammatory and proangiogenic factors, as well as the histopathological changes in gastric mucosa in response to infection. Five- to six-week-old female C57BL/6N mice were challenged with H. pylori SS1 strain. Animals were euthanized after 5-, 10-, 20-, 30-, 40- and 50-weeks post infection. mRNA and protein expression of Angpt1, Angpt2, VegfA, Tnf-α, bacterial colonization, inflammatory response and gastric lesions were evaluated. Results: A robust bacterial colonization was observed in 30 to 50 weeks-infected mice, which was accompanied by immune cell infiltration in the gastric mucosa. Compared to non-infected animals, H. pylori-colonized animals showed an upregulation in the expression of Tnf-A, Angpt2 and VegfA at the mRNA and protein levels. In contrast, Angpt1 mRNA and protein expression was downregulated in H. pylori-colonized mice. Conclusion: Our data show that H. pylori infection induces the expression of Angpt2, Tnf-A and Vegf-A in murine gastric epithelium. This may contribute to the pathogenesis of H. pylori-associated gastritis, however the significance of this should be further addressed.
- Open Access
- 20 September 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 987182
Difference in mortality rates in hospitalized COVID-19 patients identified by cytokine profile clustering using a machine learning approach: An outcome prediction alternative
COVID-19 is a disease caused by the novel Coronavirus SARS-CoV-2 causing an acute respiratory disease that can eventually lead to severe acute respiratory syndrome (SARS). An exacerbated inflammatory response is characteristic of SARS-CoV-2 infection, which leads to a cytokine release syndrome also known as cytokine storm associated with the severity of the disease. Considering the importance of this event in the immunopathology of COVID-19, this study analyses cytokine levels of hospitalized patients to identify cytokine profiles associated with severity and mortality. Using a machine learning approach, 3 clusters of COVID-19 hospitalized patients were created based on their cytokine profile. Significant differences in the mortality rate were found among the clusters, associated to different CXCL10/IL-38 ratio. The balance of a CXCL10 induced inflammation with an appropriate immune regulation mediated by the anti-inflammatory cytokine IL-38 appears to generate the adequate immune context to overrule SARS-CoV-2 infection without creating a harmful inflammatory reaction. This study supports the concept that analyzing a single cytokine is insufficient to determine the outcome of a complex disease such as COVID-19, and different strategies incorporating bioinformatic analyses considering a broader immune profile represent a more robust alternative to predict the outcome of hospitalized patients with SARS-CoV-2 infection.
- 20 September 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 987182
Open AccessDifference in mortality rates in hospitalized COVID-19 patients identified by cytokine profile clustering using a machine learning approach: An outcome prediction alternative
COVID-19 is a disease caused by the novel Coronavirus SARS-CoV-2 causing an acute respiratory disease that can eventually lead to severe acute respiratory syndrome (SARS). An exacerbated inflammatory response is characteristic of SARS-CoV-2 infection, which leads to a cytokine release syndrome also known as cytokine storm associated with the severity of the disease. Considering the importance of this event in the immunopathology of COVID-19, this study analyses cytokine levels of hospitalized patients to identify cytokine profiles associated with severity and mortality. Using a machine learning approach, 3 clusters of COVID-19 hospitalized patients were created based on their cytokine profile. Significant differences in the mortality rate were found among the clusters, associated to different CXCL10/IL-38 ratio. The balance of a CXCL10 induced inflammation with an appropriate immune regulation mediated by the anti-inflammatory cytokine IL-38 appears to generate the adequate immune context to overrule SARS-CoV-2 infection without creating a harmful inflammatory reaction. This study supports the concept that analyzing a single cytokine is insufficient to determine the outcome of a complex disease such as COVID-19, and different strategies incorporating bioinformatic analyses considering a broader immune profile represent a more robust alternative to predict the outcome of hospitalized patients with SARS-CoV-2 infection.
- Open Access
- 18 September 2021
- Published by MDPI AG in Metabolites
- Vol. 11 (9) , 637
Perturbation-Based Modeling Unveils the Autophagic Modulation of Chemosensitivity and Immunogenicity in Breast Cancer Cells
In the absence of new therapeutic strategies, chemotherapeutic drugs are the most widely used strategy against metastatic breast cancer, in spite of eliciting multiple adverse effects and having low responses with an average 5-year patient survival rate. Among the new therapeutic targets that are currently in clinical trials, here, we addressed the association between the regulation of the metabolic process of autophagy and the exposure of damage-associated molecular patterns associated (DAMPs) to immunogenic cell death (ICD), which has not been previously studied. After validating an mCHR-GFP tandem LC3 sensor capacity to report dynamic changes of the autophagic metabolic flux in response to external stimuli and demonstrating that both basal autophagy levels and response to diverse autophagy regulators fluctuate among different cell lines, we explored the interaction between autophagy modulators and chemotherapeutic agents in regards of cytotoxicity and ICD using three different breast cancer cell lines. Since these interactions are very complex and variable throughout different cell lines, we designed a perturbation-based model in which we propose specific modes of action of chemotherapeutic agents on the autophagic flux and the corresponding strategies of modulation to enhance the response to chemotherapy. Our results point towards a promising therapeutic potential of the metabolic regulation of autophagy to overcome chemotherapy resistance by eliciting ICD.
- 18 September 2021
- Published by MDPI AG in Metabolites
- Vol. 11 (9) , 637
Open AccessPerturbation-Based Modeling Unveils the Autophagic Modulation of Chemosensitivity and Immunogenicity in Breast Cancer Cells
In the absence of new therapeutic strategies, chemotherapeutic drugs are the most widely used strategy against metastatic breast cancer, in spite of eliciting multiple adverse effects and having low responses with an average 5-year patient survival rate. Among the new therapeutic targets that are currently in clinical trials, here, we addressed the association between the regulation of the metabolic process of autophagy and the exposure of damage-associated molecular patterns associated (DAMPs) to immunogenic cell death (ICD), which has not been previously studied. After validating an mCHR-GFP tandem LC3 sensor capacity to report dynamic changes of the autophagic metabolic flux in response to external stimuli and demonstrating that both basal autophagy levels and response to diverse autophagy regulators fluctuate among different cell lines, we explored the interaction between autophagy modulators and chemotherapeutic agents in regards of cytotoxicity and ICD using three different breast cancer cell lines. Since these interactions are very complex and variable throughout different cell lines, we designed a perturbation-based model in which we propose specific modes of action of chemotherapeutic agents on the autophagic flux and the corresponding strategies of modulation to enhance the response to chemotherapy. Our results point towards a promising therapeutic potential of the metabolic regulation of autophagy to overcome chemotherapy resistance by eliciting ICD.
- Open Access
- 24 September 2019
- Published by Wiley in Journal of Oncology
- Vol. 2019, 1-11
Gastric Cancer in the Era of Immune Checkpoint Blockade
Gastric cancer (GC) is one of the most important malignancies worldwide because of its high incidence and mortality. The very low survival rates are mainly related to late diagnosis and limited treatment options. GC is the final clinical outcome of a stepwise process that starts with a chronic and sustained inflammatory reaction mounted in response toHelicobacter pyloriinfection. The bacterium modulates innate and adaptive immunity presumably as part of the strategies to survive, which favors the creation of an immunosuppressive microenvironment that ultimately facilitates GC progression. T-cell exhaustion, which is characterized by elevated expression of immune checkpoint (IC) proteins, is one of the most salient manifestations of immunosuppressive microenvironments. It has been consistently demonstrated that the tumor-immune microenvironment(TIME)‐exhausted phenotype can be reverted by blocking ICs with monoclonal antibodies. Although these therapies are associated with long-lasting response rates, only a subset of patients derive clinical benefit, which varies according to tumor site. The search for biomarkers to predict the response to IC inhibition is a matter of intense investigation as this may contribute to maximize disease control, reduce side effects, and minimize cost. The approval of pembrolizumab for its use in GC has rocketed immuno-oncology research in this cancer type. In this review, we summarize the current knowledge centered around the immune contexture and recent findings in connection with IC inhibition in GC.
- 24 September 2019
- Published by Wiley in Journal of Oncology
- Vol. 2019, 1-11
Open AccessGastric Cancer in the Era of Immune Checkpoint Blockade
Gastric cancer (GC) is one of the most important malignancies worldwide because of its high incidence and mortality. The very low survival rates are mainly related to late diagnosis and limited treatment options. GC is the final clinical outcome of a stepwise process that starts with a chronic and sustained inflammatory reaction mounted in response toHelicobacter pyloriinfection. The bacterium modulates innate and adaptive immunity presumably as part of the strategies to survive, which favors the creation of an immunosuppressive microenvironment that ultimately facilitates GC progression. T-cell exhaustion, which is characterized by elevated expression of immune checkpoint (IC) proteins, is one of the most salient manifestations of immunosuppressive microenvironments. It has been consistently demonstrated that the tumor-immune microenvironment(TIME)‐exhausted phenotype can be reverted by blocking ICs with monoclonal antibodies. Although these therapies are associated with long-lasting response rates, only a subset of patients derive clinical benefit, which varies according to tumor site. The search for biomarkers to predict the response to IC inhibition is a matter of intense investigation as this may contribute to maximize disease control, reduce side effects, and minimize cost. The approval of pembrolizumab for its use in GC has rocketed immuno-oncology research in this cancer type. In this review, we summarize the current knowledge centered around the immune contexture and recent findings in connection with IC inhibition in GC.
- 13 November 2009
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 9 (1) , 564-577
Impact of Regional Variation in Bothrops asper Snake Venom on the Design of Antivenoms: Integrating Antivenomics and Neutralization Approaches
Intraspecific snake venom variations have implications in the preparation of venom pools for the generation of antivenoms. The impact of such variation in the cross-reactivity of antivenoms against Bothrops asper venom was assessed by comparing two commercial and four experimental antivenoms. All antivenoms showed similar immunorecognition pattern toward the venoms from adult and neonate specimens. They completely immunodepleted most P−III snake venom metalloproteinases (SVMPs), l-amino acid oxidases, serine proteinases, DC fragments, cysteine-rich secretory proteins (CRISPs), and C-type lectin-like proteins, and partially immunodepleted medium-sized disintegrins, phospholipases A2 (PLA2s), some serine proteinases, and P−I SVMPs. Although all antivenoms abrogated the lethal, hemorrhagic, coagulant, proteinase, and PLA2 venoms activities, monospecific experimental antivenoms were more effective than the polyspecific experimental antivenom. In addition, the commercial antivenoms, produced in horses subjected to repeated immunization cycles, showed higher neutralization than experimental polyspecific antivenom, produced by a single round of immunization. Overall, a conspicuous pattern of cross-neutralization was evident for all effects by all antivenoms, and monospecific antivenoms raised against venom from the Caribbean population were effective against venom from the Pacific population, indicating that geographic variations in venom proteomes of B. asper from Costa Rica do not result in overt variations in immunological cross-reactivity between antivenoms.
- 13 November 2009
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 9 (1) , 564-577
Impact of Regional Variation in Bothrops asper Snake Venom on the Design of Antivenoms: Integrating Antivenomics and Neutralization Approaches
Intraspecific snake venom variations have implications in the preparation of venom pools for the generation of antivenoms. The impact of such variation in the cross-reactivity of antivenoms against Bothrops asper venom was assessed by comparing two commercial and four experimental antivenoms. All antivenoms showed similar immunorecognition pattern toward the venoms from adult and neonate specimens. They completely immunodepleted most P−III snake venom metalloproteinases (SVMPs), l-amino acid oxidases, serine proteinases, DC fragments, cysteine-rich secretory proteins (CRISPs), and C-type lectin-like proteins, and partially immunodepleted medium-sized disintegrins, phospholipases A2 (PLA2s), some serine proteinases, and P−I SVMPs. Although all antivenoms abrogated the lethal, hemorrhagic, coagulant, proteinase, and PLA2 venoms activities, monospecific experimental antivenoms were more effective than the polyspecific experimental antivenom. In addition, the commercial antivenoms, produced in horses subjected to repeated immunization cycles, showed higher neutralization than experimental polyspecific antivenom, produced by a single round of immunization. Overall, a conspicuous pattern of cross-neutralization was evident for all effects by all antivenoms, and monospecific antivenoms raised against venom from the Caribbean population were effective against venom from the Pacific population, indicating that geographic variations in venom proteomes of B. asper from Costa Rica do not result in overt variations in immunological cross-reactivity between antivenoms.